The impact of 18 FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 2, 2002, Pages 339-350

  Mah, Katherine ^a   Caldwell, Curtis B ^b,c   Ung, Yee C ^a,b   Danjoux, Cyril E ^a,b   Balogh, Judith M ^a,b   Ganguli, S Nimu ^b,c   Ehrlich, Lisa E ^b,c   Tirona, Romeo ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

3D CRT; FDG PET; Image fusion; Lung cancer; Radiation therapy planning; Target definition

Indexed keywords

CELLS; COMPUTER SIMULATION; COMPUTERIZED TOMOGRAPHY; DOSIMETRY; IMAGE PROCESSING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY;

TREATMENT PLANNING;

ONCOLOGY;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FEMALE; HISTOGRAM; HUMAN; IMAGE ANALYSIS; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MALE; PALLIATIVE THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TARGET ORGAN; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036471788     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01824-7     Document Type: Article

References (38)

1. Dose escalation for non-small cell lung cancer using conformal radiation therapy
2. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
3. Preliminary results of 92.4 Gy or more for non-small cell lung cancer
4. 18FDG-Hybrid PET fusion. Accepted for publication
5. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer
6. Comparison of treatment techniques for lung cancer
7. Clinical variability of target volume description in conformal radiotherapy planning
8. PET in lung cancer
9. Clinical and surgical staging of non-small cell lung cancer
10. MR imaging of thoracic lymph nodes. A comparison of computed tomography and positron emission tomography
11. Preoperative staging of non-small-cell lung cancer with positron-emission tomography
12. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras
13. Metastases from non-small lung cancer; Mediastinal staging in the 1990s. Meta-analytic comparison of PET and CT
14. Towards multidimensional radiotherapy (MD-CRT); Biological imaging and biological conformality
15. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer; High impact in patients with atelectasis
16. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer
17. The impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
18. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer; Challenges and prospects
19. Image fusion of F-18 FDG PET and CT. Is there a role in 3D-radiation treatment planning of non-small cell lung cancer?
20. PET imaging using dual-headed gamma cameras; An update
21. Coincidence imaging with a dual-head scintillation camera
22. Fusing 18fluorodeoxyglucose (FDG)-hybrid PET to CT images significantly alters treatment planning in the radical treatment of non-small cell carcinoma of the lung
23. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer
24. Predicting radiation response
25. Tolerance of normal tissue to therapeutic irradiation
26. Radiation injury to the heart
27. Biological target volume (BTV) determined with dose response data from the correlation between metabolic rate of glucose (MRG) measured with 18F-FDG PET and pathologic complete response in stage III NSCLC
28. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy; Preliminary findings
29. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer
30. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions
31. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography
32. Impact of respiratory movement on the computed tomographic images on small lung tumors in three-dimensional (3D) radiotherapy
33. Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer
34. Fluoroscopic real-time tumor-tracking radiation treatment can reduce internal margin and set-up margin of planning target volume for lung tumors
35. Is spiral CT too fast for radiation therapy planning of thoracic neoplasms?
36. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?
37. Long term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer
38. Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's patients